B-Dmd KO(del45-50) mice

      C57BL/6JNifdc-Dmdtm1(Dmd Exon45-50 del)Bcgen /Bcgen • 113915

      B-Dmd KO(del45-50) mice

      Product nameB-Dmd KO(del45-50) mice
      Catalog number113915
      Strain nameC57BL/6JNifdc-Dmdtm1(Dmd Exon45-50 del)Bcgen /Bcgen
      Strain backgroundC57BL/6JNifdc
      NCBI gene ID (Mouse)
      Aliasesdys; mdx; pke; Dp71; Dp427; DXSmh7; DXSmh9

      在此页面上

      • Description
      • Targeting strategy
      • Phenotypic analysis

      海报

      查看全部

        发表文章

          Description
          • Duchenne muscular dystrophy (DMD) is a severe, progressive, muscle-wasting disease that leads to difficulties with movement and premature death.
          • Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene. These mutations frequently entail deletions of one or more exons, which disrupt the open reading frame and introduce a premature stop codon. This leads to the production of a nonfunctional truncated dystrophin protein, resulting in a severe muscle degeneration phenotype.
          • The exons 45-50 of mouse Dmd gene were deleted in B-Dmd KO(del45-50) mice.
          • Mouse Dmd mRNA and DMD protein were detectable in wild-type C57BL/6JNifdc mice but not in homozygous B-Dmd KO(del45-50) mice. Gastrocnemius and soleus muscle from homozygous B-Dmd KO(del45-50) mice displayed centrally-located nuclei, inflammatory cell infiltration and muscular atrophy. The forelimb strength in homozygous B-Dmd KO(del45-50) mice was significant weaker than that in wild-type control mice, and the latency to fall, rodspeed and total distance in rotarod tests were significantly decreased in homozygous B-Dmd KO(del45-50) mice, showing the impairment of motor coordination and balance in homozygous B-Dmd KO(del45-50) mice.
          • This product is used for pharmacodynamics of Duchenne muscular dystrophy.
          Targeting strategy

          Gene targeting strategy for B-Dmd KO(del45-50) mice. The exons 45-50 of mouse Dmd gene were deleted in B-Dmd KO(del45-50) mice.

          mRNA expression analysis

          Strain specific analysis of DMD mRNA expression in wild-type C57BL/6JNifdc mice and B-Dmd KO(del45-50) mice by RT-PCR. Heart and skeletal muscle RNA were isolated from wild-type C57BL/6JNifdc mice (+/+) and homozygous B-Dmd KO(del45-50) mice (-/Y), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse Dmd primers. Dmd mRNA was detectable in wild-type C57BL/6JNifdc mice (+/+) but not the homozygous B-Dmd KO(del45-50) mice (-/Y).

          Protein expression analysis

          Western blot analysis of DMD protein expression in B-Dmd KO(del45-50) mice. Various tissue lysates were collected from wild-type C57BL/6JNifdc mice (+/+) and B-Dmd KO(del45-50) mice (-/Y), and then analyzed by western blot with anti-Dystrophin antibody (Sigma, D8168). 50 μg total proteins were loaded for western blotting analysis. DMD was detectable in heart, skeletal muscle and skin from wild-type C57BL/6JNifdc mice (+/+) but not homozygous B-Dmd KO(del45-50) mice (-/Y).

          Histopathological analysis

          Representative histological images of skeletal muscle from wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice. Gastrocnemius and soleus muscle sections from 9-week-old wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice were presented to display histopathological phenotypes. Gastrocnemius and soleus muscle were stained with hematoxylin and eosin (H&E). Tissue histology was normal in wild-type control mice, but the muscle from homozygous B-Dmd KO(del45-50) mice displayed centrally-located nuclei (black arrow), inflammatory cell infiltration and muscular atrophy. Myofiber necrosis (red arrow) was also observed in 25-week-old B-Dmd KO(del45-50) mice. All those abnormalities were more pronounced in the gastrocnemius muscle in homozygous B-Dmd KO(del45-50) mice.

          Behavioral performance analysis

          Behavioral performance in wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice. Grip strength tests were conducted to assay the behavioral performance in wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice (male, 3-month-old, n=12). Grip strength results showed the strength produced by forelimb was ~18 N/kg in homozygous B-Dmd KO(del45-50) mice, which was significant weaker than that in wild-type control mice. All grip strength measurements are normalized to the individual animal’s body weight. Values are expressed as mean ± SEM. Significance was determined by unpaired t test.  *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

          Behavioral performance in wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice. Rotarod tests were conducted to assay the behavioral performance in wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice (male, 3-month-old, n=12). Rotarod tests were performed to assay the motor coordination. The latency to fall, rodspeed and total distance were significantly decreased in homozygous B-Dmd KO(del45-50) mice, showing the impairment of motor coordination and balance. Values are expressed as mean ± SEM. Significance was determined by unpaired t test.  *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. 

          * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-Dmd KO(del45-50) mice] (Cat# 113915) was purchased from Biocytogen.
          站点地图